Humana (NYSE:HUM) Upgraded at Royal Bank Of Canada

Royal Bank Of Canada upgraded shares of Humana (NYSE:HUM – Free Report) from a sector perform rating to an outperform rating in a report released on Monday, MarketBeat.com reports. They currently have $563.00 price target on the insurance provider’s stock, up from their previous price target of $415.00.

Several other equities research analysts have also issued reports on the company. JPMorgan Chase & Co. lifted their price objective on Humana from $393.00 to $484.00 and gave the company a “neutral” rating in a research note on Tuesday, November 10th. TD Cowen upped their target price on Humana from $370.00 to $430.00 and gave the stock a “hold” rating in a research note on Wednesday, November 11th. Oppenheimer raised their price target on Humana from $475.00 to $525.00 and gave the company an “outperform” rating in a report on Monday, October 12th. Cantor Fitzgerald raised their price target on Humana from $460.00 to $495.00 and gave the company an “overweight” rating in a report on Monday, November 9th. Finally, Guggenheim lifted their price target on Humana from $471.00 to $521.00 and gave the company a “buy” rating in a research report on Monday, November 9th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $484.78.

Read Our Latest Report on HUM

Humana Stock Performance

Humana stock opened at $386.73 on Monday. Humana has a 1-year low of $163.11 and a 1-year high of $462.87. The company has a current ratio of 1.65, a quick ratio of 1.65 and a debt-to-equity ratio of 0.61. The firm has a market capitalization of $46.45 billion, a PE ratio of 37.62, a price-to-earnings-growth ratio of 2.11 and a beta of 0.65. The firm’s 50 day simple moving average is $410.26 and its 200 day simple moving average is $320.44.

Humana (NYSE:HUM – Get Free Report) last announced its quarterly earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, beating the consensus estimate of ($1.00) by $0.30. The firm had revenue of $41.16 billion during the quarter, compared to the consensus estimate of $40.87 billion. Humana had a net margin of 0.81% and a return on equity of 8.50%. The business’s quarterly revenue was up 26.1% compared to the same quarter last year. During the same period last year, the firm earned $3.24 EPS. Humana has set its FY 2026 guidance at 9.500- EPS. As a group, analysts expect that Humana will post 9.66 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be issued a dividend of $0.8850 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, December 24th. Humana’s payout ratio is currently 34.44%.

Insider Transactions at Humana

In related news, insider Joseph Ventura sold 5,495 shares of the company’s stock in a transaction on Monday, November 9th. The shares were sold at an average price of $433.85, for a total value of $2,384,005.75. Following the completion of the transaction, the insider directly owned 21,910 shares in the company, valued at approximately $9,505,653.50. The trade was a 20.05% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.20% of the company’s stock.

Institutional Investors Weigh In On Humana

Large investors have recently added to or reduced their stakes in the company. Johnson Financial Group Inc. purchased a new position in shares of Humana in the 2nd quarter worth about $26,000. Trust Co. of Vermont bought a new position in shares of Humana during the 2nd quarter valued at about $28,000. Bogart Wealth LLC raised its holdings in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock valued at $29,000 after buying an additional 48 shares in the last quarter. MidFirst Bank purchased a new position in shares of Humana during the 2nd quarter valued at about $35,000. Finally, Highland Investment Advisors LLC purchased a new position in shares of Humana during the 2nd quarter valued at about $43,000. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Key Humana News

Investors following HUM have been watching these news items:

  • Positive Sentiment: Royal Bank of Canada upgraded Humana to “Outperform,” adding to a generally favorable analyst view of the shares. Royal Bank of Canada Upgrades Humana to Outperform
  • Neutral Sentiment: Humana expects some Louisville employees to return to office work in 2027; the policy appears to have limited direct relevance to near-term results. Humana to mandate office work for select Louisville staff
  • Negative Sentiment: CMS’s proposed CRUSH rule would strengthen Medicare Advantage audits and expand recovery of unsupported risk-adjustment payments, including through extrapolation. CMS estimates the audit provisions could generate about $9 billion in collections per payment year. Because Medicare Advantage is central to Humana’s business, investors fear higher repayment liabilities and regulatory costs. The rule is proposed, not final, but the concern has weighed on Humana and other health insurers. Humana slides as proposed Medicare Advantage audit crackdown pressures insurers

About Humana

(Get Free Report)

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.

Recommended Stories

Analyst Recommendations for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.